Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Merck Serono and Fast Forward to accelerate development of MS treatments

March 19, 2009

Cephalon reports positive results from phase II Nuvigil study

March 19, 2009

Questcor submits sNDA to FDA for H.P. Acthar gel for infantile spasms

March 19, 2009

Preliminary data show effects on sleep and memory with ramelteon in Parkinson's disease patients

March 19, 2009

NST-0021 prevents neurodegeneration in vivo in Alzheimer's model

March 19, 2009

Pimavanserin does not worsen parkinsonism in patients with PD and psychosis

March 19, 2009

CytRx's arimoclomol improves stroke recovery in preclinical trial in rats

March 18, 2009

Memantine beneficial in patients with Parkinson's disease dementia or dementia with Lewy bodies

March 18, 2009

Servier claims novel napthalene derivatives that inhibit melatonin receptors

March 18, 2009

Prolonged-release ropinirole improves symptom control in Parkinson's patients

March 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...